Arrive Partners with AllMart Marketplace to Launch its Smart Mailbox Solution in Antigua
Autonomous delivery testing expected to follow in second half of 2024VANCOUVER, BC and INDIANAPOLIS, IN / ACCESSWIRE / February 8,...
Year: 2024
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
Financials for Third Quarter Fiscal Year 2024 Ended December 31, 2023 will be released on February 14, 2024NORTHVALE, NJ /...
Halberd and Mississippi State University to Commence Stage II Advanced TBI Nasal Spray Testing
JACKSON CENTER, PA / ACCESSWIRE / February 8, 2024 / Halberd Corporation's (OTC PINK:HALB) Traumatic Brain Injury (TBI) mitigating nasal...
Innovaccer Recognized as the 2024 Best in KLAS CRM Solution
The data platform company scored 93.6 out of 100 for its CRM solution, and 88+ across all customer experience pillars,...
Avant Brands Executes Four New Export Agreements
KELOWNA, BC / ACCESSWIRE / February 8, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), an award-winning cannabis...
Celebrating Its Fifth Anniversary, Genesis Reference Laboratories Announces Testing Upgrades
Leading diagnostics laboratory Genesis Reference Laboratories, which recently celebrated five years in the industry, is excited to announce it has...
Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Jones Healthcare Group’s Qube Pro Wins Prestigious PAC Global Awards
Innovation and Sustainability Lead to Double Award Win for Qube Pro at PAC GlobalLondon, Ontario--(Newsfile Corp. - February 8, 2024)...
Planet 13 Announces Expansion of Leadership Team and Board
LAS VEGAS, NV / ACCESSWIRE / February 8, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),...
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
ANN ARBOR, MI / ACCESSWIRE / February 8, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary...
Sai Life Sciences releases its Sustainability Report 2023
Sustainability Report 2023 Sustainability Report 2023 HYDERABAD, India, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Sai Life Sciences, a leading global...
A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius
A clearer vision for surgical robotics: CMR Surgical announces significant update to Versius CMR Surgical launches vLimeLite * a new...
SweetWater Brewing and Atlanta Track Club Join Forces to Promote Active Lifestyles
SweetWater Brewing is now the Official Beer Partner of the Atlanta Track Club SweetWater Brewing Company x Atlanta Track Club...
Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa
• Initial clinical data suggest the potential of B-VEC to treat lesions in the eye of DEB patients and additional...
Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™
- Award Recognizes Approval of Amicus Therapeutics’ Two-component Therapy for the Treatment of Late-onset Pompe Disease -PRINCETON, N.J., Feb. 08,...
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD
– Both dose levels (2E11 & 6E10) demonstrate potential best-in-class clinical activity in hard-to-treat patients including treatment burden reduction and...
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
SUNNYVALE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on...
Foghorn Provides Pipeline Update on FHD-909 BRM Selective Inhibitor
CAMBRIDGE, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new...
Veru Reports Fiscal 2024 First Quarter Financial Highlights
—Company receives FDA IND clearance for the development of enobosarm in combination with GLP-1 drugs for potentially higher quality weight...
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
WAYNE, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth...